These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

244 related articles for article (PubMed ID: 17266161)

  • 1. Truncation limits for CT marker ratios in prenatal screening for Down syndrome.
    Wald NJ; Bestwick JP; Morris JK
    Prenat Diagn; 2007 Feb; 27(2):187-8. PubMed ID: 17266161
    [No Abstract]   [Full Text] [Related]  

  • 2. Cross-trimester marker ratios in prenatal screening for Down syndrome.
    Wald NJ; Bestwick JP; Morris JK
    Prenat Diagn; 2006 Jun; 26(6):514-23. PubMed ID: 16739232
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect on Down syndrome screening performance of adjusting for marker levels in a previous pregnancy.
    Wald NJ; Barnes IM; Birger R; Huttly W
    Prenat Diagn; 2006 Jun; 26(6):539-44. PubMed ID: 16634123
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Combining first and second trimester markers for Down syndrome screening: think twice.
    Cocciolone R; Brameld K; O'Leary P; Haan E; Muller P; Shand K
    Aust N Z J Obstet Gynaecol; 2008 Oct; 48(5):492-500. PubMed ID: 19032666
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Unconjugated estriol values between 14 and 22 weeks of gestation in relation to prenatal screening for Down syndrome.
    Bestwick JP; Huttly WJ; Wald NJ
    Prenat Diagn; 2012 Mar; 32(3):299-301. PubMed ID: 22430732
    [No Abstract]   [Full Text] [Related]  

  • 6. Integrated, sequential, and contingent screening for Down syndrome - local needs should drive methodology.
    Wyatt P
    Prenat Diagn; 2007 Feb; 27(2):186-7. PubMed ID: 17266162
    [No Abstract]   [Full Text] [Related]  

  • 7. Repeated measures screening for Down's Syndrome.
    Wright DE; Bradbury I
    BJOG; 2005 Jan; 112(1):80-3. PubMed ID: 15663402
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Contingent screening for Down syndrome is an efficient alternative to non-disclosure sequential screening.
    Wright D; Bradbury I; Benn P; Cuckle H; Ritchie K
    Prenat Diagn; 2004 Oct; 24(10):762-6. PubMed ID: 15503281
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Second-trimester maternal serum screening for Down syndrome in Mainland China.
    Liao C; Huang Y; Li D; Song S; Yi C; Zhou J
    Prenat Diagn; 2006 Dec; 26(13):1271-2. PubMed ID: 17139699
    [No Abstract]   [Full Text] [Related]  

  • 10. Hyperglycosylated-hCG (h-hCG) and Down syndrome screening in the first and second trimesters of pregnancy.
    Palomaki GE; Neveux LM; Haddow JE; Wyatt P
    Prenat Diagn; 2007 Sep; 27(9):808-13. PubMed ID: 17590886
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Screening for Down syndrome using first-trimester combined screening followed by second trimester ultrasound examination in an unselected population].
    Rozenberg P; Bussières L; Chevret S; Bernard JP; Malagrida L; Cuckle H; Chabry C; Durand-Zaleski I; Bidat L; Lacroix I; Moulis M; Roger M; Jacquemot MC; Bault JP; Boukobza P; Boccara P; Vialat F; Giudicelli Y; Ville Y
    Gynecol Obstet Fertil; 2007 Apr; 35(4):303-11. PubMed ID: 17350315
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Current methods of prenatal screening for Down syndrome and other fetal abnormalities.
    Saller DN; Canick JA
    Clin Obstet Gynecol; 2008 Mar; 51(1):24-36. PubMed ID: 18303497
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Schwangerschafts protein 1 (SP1) adds little to the age-related detection of fetal Down syndrome in the first trimester of pregnancy.
    Kornman LH; Morssink LP; Ten Hoor KA; De Wolf BT; Kloosterman MD; Beekhuis JR; Mantingh A
    Prenat Diagn; 1998 Oct; 18(10):1086-90. PubMed ID: 9826903
    [TBL] [Abstract][Full Text] [Related]  

  • 14. First- and second-trimester screening: detection of aneuploidies other than Down syndrome.
    Breathnach FM; Malone FD; Lambert-Messerlian G; Cuckle HS; Porter TF; Nyberg DA; Comstock CH; Saade GR; Berkowitz RL; Klugman S; Dugoff L; Craigo SD; Timor-Tritsch IE; Carr SR; Wolfe HM; Tripp T; Bianchi DW; D'Alton ME;
    Obstet Gynecol; 2007 Sep; 110(3):651-7. PubMed ID: 17766613
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Combined test + inhibin A at week 13 in contingent sequential testing: an interesting alternative for first-trimester prenatal screening for Down syndrome.
    Ramos-Corpas DJ; Santiago JC
    Prenat Diagn; 2008 Sep; 28(9):833-8. PubMed ID: 18661488
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CT ratios: parameter estimates are inconsistent with SURUSS publications?
    Wright D; Bradbury I; Benn P; Nix B; Spencer K; Cuckle H
    Prenat Diagn; 2006 Oct; 26(10):991-2; author reply 994. PubMed ID: 17029298
    [No Abstract]   [Full Text] [Related]  

  • 17. Anomalous marker patterns in Down syndrome screening.
    Wald NJ; Bestwick JP; Barnes IM; Kellner LH
    Prenat Diagn; 2007 Feb; 27(2):185-6. PubMed ID: 17266168
    [No Abstract]   [Full Text] [Related]  

  • 18. Bead-based multiplexed immunoassays to identify new biomarkers in maternal serum to improve first trimester Down syndrome screening.
    Koster MP; Pennings JL; Imholz S; Rodenburg W; Visser GH; de Vries A; Schielen PC
    Prenat Diagn; 2009 Sep; 29(9):857-62. PubMed ID: 19488973
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparing three screening strategies for combining first- and second-trimester Down syndrome markers.
    Palomaki GE; Steinort K; Knight GJ; Haddow JE
    Obstet Gynecol; 2006 Feb; 107(2 Pt 1):367-75. PubMed ID: 16449126
    [TBL] [Abstract][Full Text] [Related]  

  • 20. First-trimester screening markers are altered in pregnancies conceived after IVF/ICSI.
    Gjerris AC; Loft A; Pinborg A; Christiansen M; Tabor A
    Ultrasound Obstet Gynecol; 2009 Jan; 33(1):8-17. PubMed ID: 19115229
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.